sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > Others > Signaling pathway-Others > PBTZ169
PBTZ169  
Catalog No. T3583    CAS 1377239-83-2
Pack Size
Availability
Price/USD
Quantity
5mg
In stock
102.00
10mg
In stock
170.00
25mg
In stock
309.00
50mg
In stock
553.00
100mg
In stock
808.00
1g
Get quote
0.00
5g
Get quote
0.00
10mM * 1mL (in DMSO)
In stock
112.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.73% COA Datasheet HNMR HPLC
Biological Activity:

Product Description:

PBTZ169 inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.

Target:
DprE1;
Research Area:
Respiratory system/ Immunology system
Chemical Information:
Molecular Weight 456.48
Formula C20H23F3N4O3S
CAS Number 1377239-83-2
Solubility DMSO:6.4 mg/mL
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
  • The compound is not included in our libraries at this moment.
Product Recommendations
  • Batefenterol, Batefenterol (GSK961081, TD-5959) is a muscarinic receptor antagonist and β2-adrenoceptor agonist. I...
  • GLPG1690, GLPG-1690, an autotaxin inhibitor, currently being evaluated in an exploratory phase 2 study in idio...
  • BTZ043, BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis ...
  • GAL-021, GAL-021 an intravenous BKCa-channel blocker.
  • NIH-12848, NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) with an I...

 

Reference

If you have additional questions, Please send us a message. * Required